oxaprozin 300 MG Oral Capsule

RxCUI
2668162
RxNorm name
oxaprozin 300 MG Oral Capsule
Display name
oxaprozin 300 MG Oral Capsule
Full name
oxaprozin 300 MG Oral Capsule
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:08

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
OxaprozinOXAPROZINSOLA Pharmaceuticals, LLC450f5941-7f10-42fe-e063-6394a90a48032025-12-03Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2668162
COXANTOOXAPROZINSOLA Pharmaceuticals, LLC918127f0-9f2a-4edf-a2f7-07c01aa52bb52025-10-20Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2668162

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 2 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
918127f0-9f2a-4edf-a2f7-07c01aa52bb5oxaprozin 300 MG Oral Capsule [PSN] · oxaprozin 300 MG Oral Capsule [SCD] · oxaprozin 300 MG Oral Capsule [SY]32These highlights do not include all the information needed to use COXANTO safely and effectively. See full prescribing information for COXANTO. COXANTO ® (oxaprozin) capsules, for oral use Initial U.S. Approval: 199220251020
450f5941-7f10-42fe-e063-6394a90a4803oxaprozin 300 MG Oral Capsule [PSN] · oxaprozin 300 MG Oral Capsule [SCD] · oxaprozin 300 MG Oral Capsule [SY]31These highlights do not include all the information needed to use Oxaprozin safely and effectively. See full prescribing information for OXAPROZIN CAPSULES. OXAPROZIN CAPSULES, for oral use Initial U.S. Approval: 199220251203